Cargando…
Resistance, remission, and qualitative differences in HIV chemotherapy.
To understand the role of qualitative differences in multidrug chemotherapy for human immunodeficiency virus (HIV) infection in virus remission and drug resistance, we designed a mathematical system that models HIV multidrug chemotherapy including uninfected CD4+ T cells, infected CD4+ T cells, and...
Autores principales: | Kirschner, D E, Webb, G F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627652/ https://www.ncbi.nlm.nih.gov/pubmed/9284371 |
Ejemplares similares
-
VAD chemotherapy as remission induction for multiple myeloma.
por: Anderson, H., et al.
Publicado: (1995) -
Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: Jiang, Bing, et al.
Publicado: (2021) -
Ethical issues in HIV remission trials
por: Eyal, Nir, et al.
Publicado: (2018) -
Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy
por: Orcurto, Angela, et al.
Publicado: (2014) -
Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy
por: Hadisantoso, Dwi Wahyunianto, et al.
Publicado: (2022)